Utah Medical Products, Inc. (UTMD)
| Market Cap | 227.73M +24.4% |
| Revenue (ttm) | 38.52M -5.8% |
| Net Income | 11.29M -18.7% |
| EPS | 3.48 -12.1% |
| Shares Out | 3.19M |
| PE Ratio | 20.28 |
| Forward PE | n/a |
| Dividend | $1.24 (1.74%) |
| Ex-Dividend Date | Mar 17, 2026 |
| Volume | 2,629 |
| Open | 70.93 |
| Previous Close | 70.65 |
| Day's Range | 70.93 - 71.50 |
| 52-Week Range | n/a |
| Beta | 0.35 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 1, 2026 |
About UTMD
Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK fee... [Read more]
Financial Performance
In 2025, Utah Medical Products's revenue was $38.52 million, a decrease of -5.83% compared to the previous year's $40.90 million. Earnings were $11.29 million, a decrease of -18.65%.
Financial StatementsNews
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESS Newswire / February 4, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) ...
Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend
SALT LAKE CITY, UT / ACCESS Newswire / November 4, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Kevin C. Timken, Esq to its Board of Directors.
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2025
SALT LAKE CITY, UT / ACCESS Newswire / October 23, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2025 financial results that w...
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2025
SALT LAKE CITY, UT / ACCESS Newswire / July 24, 2025 / Utah Medical Products, Inc. [Nasdaq:UTMD] reports second calendar quarter (2Q) and first half (1H) 2025 financial results which are consistent wi...
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2025
SALT LAKE CITY, UT / ACCESS Newswire / April 29, 2025 / In the first calendar quarter (1Q) of 2025, Utah Medical Products, Inc. (Nasdaq:UTMD) attained financial results consistent with its previously ...
UTMD Reports Year 2024 and Fourth Quarter Financial Performance
SALT LAKE CITY, UT / ACCESS Newswire / January 28, 2025 / With Revenues 19% lower, Net Income 17% lower and Earnings Per Share (EPS) 13% lower than in 2023, Utah Medical Products, Inc. (NASDAQ:UTMD) c...
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024
SALT LAKE CITY, UT / ACCESSWIRE / October 29, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2024 financial results that were w...
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024
SALT LAKE CITY, UT / ACCESSWIRE / July 25, 2024 / As previously projected, Utah Medical Products, Inc. (Nasdaq:UTMD) realized second calendar quarter (2Q) and first half (1H) 2024 financial results wh...
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024
SALT LAKE CITY, UT / ACCESSWIRE / April 25, 2024 / In the first calendar quarter (1Q) of 2024, Utah Medical Products, Inc. (NASDAQ:UTMD) attained financial results consistent with its previously annou...
UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance
SALT LAKE CITY, UT, Jan. 30, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – With Revenues 4% lower and Net Income and Earnings Per Share 1% higher than in 2022, Utah Medical Products, Inc. (Nasdaq: UTMD)...
Utah Medical Products, Inc. Increases Regular Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / October 31, 2023 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share...
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2023
SALT LAKE CITY, UT, Oct. 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Utah Medical Products, Inc. [Nasdaq: UTMD], despite a difficult third calendar quarter (3Q), achieved financial results for nin...
UTMD Updates Status of Filshie Product Liability Lawsuits in the U.S.
SALT LAKE CITY, UT / ACCESSWIRE / August 31, 2023 / As Utah Medical Products, Inc.'s (NASDAQ:UTMD's) stockholders know, the following disclosure was included in the Company's 2022 SEC 10-K annual repo...
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2023
SALT LAKE CITY, UT, July 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Utah Medical Products, Inc. [Nasdaq: UTMD] achieved second calendar quarter (2Q) and first half (1H) 2023 financial results con...
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2023
SALT LAKE CITY, UT, April 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - In the first calendar quarter (1Q) of 2023, Utah Medical Products, Inc. (Nasdaq: UTMD) attained financial results consistent w...
UTMD Reports Audited Year 2022 and Fourth Quarter Financial Performance
SALT LAKE CITY, UT, Jan. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Utah Medical Products, Inc. (Nasdaq: UTMD) finished the calendar year with a solid fourth quarter (4Q) performance, which allow...
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022
SALT LAKE CITY, UT, Oct. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire - In the third calendar quarter (3Q) of 2022, despite significant cost inflation, supply chain disruption, litigation expenses an...
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2022
SALT LAKE CITY, UT , July 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --UTMD achieved second calendar quarter (2Q) and first half (1H) 2022 financial results better than those anticipated in its beg...
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2022
SALT LAKE CITY, UT, April 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – In the first calendar quarter (1Q) of 2022, Utah Medical Products, Inc. (Nasdaq: UTMD) attained financial results consistent w...
UTMD Reports Audited Year 2021 and Fourth Quarter Financial Performance
Salt Lake City, Utah, Feb. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- The fourth calendar quarter (4Q) of 2021 financial results demonstrate Utah Medical Products, Inc.'s (Nasdaq: UTMD's) contin...
Utah Medical Products, Inc. Announces Special Dividend
SALT LAKE CITY, UT / ACCESSWIRE / November 2, 2021 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a special cash dividend of two dollars ($2.00) per share o...
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2021
Salt Lake City, Utah, July 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- The second calendar quarter (2Q) of 2021 financial results were dramatically different from 2Q 2020 because 2Q 2020 results ...
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2021
Salt Lake City, Utah, April 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Because of the aberration in results which began in March 2020 due to the impact of restrictions on “nonessential” medical ...
UTMD Reports Financial Performance for Third Quarter and Nine Months of Year 2020
Salt Lake City, UT, Oct. 27, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire --For the third calendar quarter (3Q) and first nine months (9M) of 2020, Utah Medical Products, Inc. (Nasdaq: UTMD) reports fina...
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2020
Salt Lake City, Utah, July 28, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- As many of the gynecology devices provided by Utah Medical Products, Inc. (Nasdaq: UTMD) are used in “nonessential” or “el...